About
Partnering
Responsibility
People and Culture
News
Contact
Change Language

News

Refine by category
Refine by year
- 2020
- 2019
- 2018
- Archive

Press Releases —

ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe

08 Jan 2020

ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical compa
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders

17 Dec 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focus
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

27 Nov 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

07 Nov 2019

Third quarter 2019 revenue of $120 million Third quarter 2019 net loss of $119 million Third quarter 2019
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

24 Oct 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

25 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

24 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more

Featured News

Get up-to-date news direct to your inbox.

Name

Email

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

04 Jan 2019

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan ri
Learn more

About
Responsibility
People and Culture
News
Contact

Terms and Conditions
Privacy Policy
Recruitment Scams
Information Sources

Copyright 2020 Abcur English®. All Rights Reserved